Henry A Fernandez Royalty Pharma PLC (RPRX) insider trading activity

Henry A Fernandez is Director of Royalty Pharma plc. Currently has a direct ownership of 54,002 shares of RPRX, which is worth approximately $1.35 Million. The most recent transaction as insider was on Sep 30, 2024, when has been sold 1,342 shares (Class A Ordinary Shares) at a price of $27.92 per share, resulting in proceeds of $37,468. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54K

2.55% 3M change

37.15% 12M change

Total Value Held $1.35 Million

Henry A Fernandez Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 30 2024	BUY Grant, award, or other acquisition	$37,468 $27.92 p/Share	1,342 Added 2.42%	54,002 Class A Ordinary Shares
Jun 28 2024	BUY Grant, award, or other acquisition	$37,493 $26.8 p/Share	1,399 Added 2.59%	52,660 Class A Ordinary Shares
Jun 07 2024	BUY Grant, award, or other acquisition	-	9,293 Added 15.35%	51,261 Class A Ordinary Shares
Mar 28 2024	BUY Grant, award, or other acquisition	$37,485 $30.23 p/Share	1,240 Added 2.87%	41,968 Class A Ordinary Shares
Dec 29 2023	BUY Grant, award, or other acquisition	$37,491 $27.71 p/Share	1,353 Added 3.22%	40,728 Class A Ordinary Shares
Sep 29 2023	BUY Grant, award, or other acquisition	$37,478 $27.08 p/Share	1,384 Added 3.4%	39,375 Class A Ordinary Shares
Jun 30 2023	BUY Grant, award, or other acquisition	$37,484 $31.03 p/Share	1,208 Added 3.08%	37,991 Class A Ordinary Shares
Jun 23 2023	BUY Grant, award, or other acquisition	-	7,747 Added 17.4%	36,783 Class A Ordinary Shares
Mar 31 2023	BUY Grant, award, or other acquisition	$37,480 $35.73 p/Share	1,049 Added 3.49%	29,036 Class A Ordinary Shares
Dec 30 2022	BUY Grant, award, or other acquisition	$37,493 $39.76 p/Share	943 Added 3.26%	27,987 Class A Ordinary Shares
Sep 30 2022	BUY Grant, award, or other acquisition	$37,488 $41.06 p/Share	913 Added 3.27%	27,044 Class A Ordinary Shares
Jun 30 2022	BUY Grant, award, or other acquisition	$37,493 $41.52 p/Share	903 Added 3.34%	26,131 Class A Ordinary Shares
Jun 24 2022	BUY Grant, award, or other acquisition	-	6,328 Added 20.05%	25,228 Class A Ordinary Shares
Mar 31 2022	BUY Grant, award, or other acquisition	$37,471 $38.87 p/Share	964 Added 4.85%	18,900 Class A Ordinary Shares
Dec 31 2021	BUY Grant, award, or other acquisition	$37,467 $39.11 p/Share	958 Added 5.07%	17,936 Class A Ordinary Shares
Sep 30 2021	BUY Grant, award, or other acquisition	$37,498 $37.8 p/Share	992 Added 5.52%	16,978 Class A Ordinary Shares
Jun 30 2021	BUY Grant, award, or other acquisition	$37,488 $43.04 p/Share	871 Added 5.17%	15,986 Class A Ordinary Shares
Jun 25 2021	BUY Grant, award, or other acquisition	-	5,726 Added 27.47%	15,115 Class A Ordinary Shares
Mar 31 2021	BUY Grant, award, or other acquisition	$37,454 $45.9 p/Share	816 Added 7.89%	9,529 Class A Ordinary Shares
Dec 31 2020	BUY Grant, award, or other acquisition	$37,466 $45.69 p/Share	820 Added 8.6%	8,713 Class A Ordinary Shares
Sep 30 2020	BUY Grant, award, or other acquisition	$25,237 $41.17 p/Share	613 Added 7.21%	7,893 Class A Ordinary Shares

Also insider at

MSCI

MSCI Inc. Financial Services

Chairman and CEO

HAF